Showing results (41-50 of 126) with videos related to

Sort By:
Pageof 13
HIV Medicine|October 6, 2025
Blood pressure and metabolic outcomes after efavirenz- or dolutegravir-based therapy started in acute HIV infectionPhillip Chan, Sarah Moreland, Carlo Sacdalan, et al.
Journal of Medical Primatology|July 28, 2017
CD4+ Cell infiltration into subcutaneous adipose tissue is not indicative of productively infected cells during acute SHIV infectionDenise C Hsu, Matthew D Wegner, Piyanate Sunyakumthorn, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 24, 2020
Large transmission cluster of acute hepatitis C identified among HIV-positive men who have sex with men in Bangkok, ThailandWin M Han, Donn J Colby, Apichaya Khlaiphuengsin, et al.
JCI Insight|June 20, 2020
Protein-based, but not viral vector alone, HIV vaccine boosting drives an IgG1-biased polyfunctional humoral immune responseStephanie Fischinger, Sally Shin, Carolyn M Boudreau, et al.
Open Forum Infectious Diseases|October 2, 2020
Inflammatory Biomarkers Do Not Differ Between Persistently Seronegative vs Seropositive People With HIV After Treatment in Early Acute HIV InfectionCatherine W Cai, Suteeraporn Pinyakorn, Eugène Kroon, et al.
AIDS Research and Therapy|February 7, 2025
Impaired creatinine-based estimated glomerular filtration rate in Thai individuals switching to dolutegravir: illustrating the role of cystatin C testing to aid clinical decision makingCarlo Sacdalan, Curtis Austin, Aswathy Varma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2024
Adaptive NK Cells Rapidly Expand during Acute HIV Infection and Persist Despite Early Initiation of Antiretroviral TherapyAnna C Hearps, Jingling Zhou, Paul A Agius, et al.
AIDS (London, England)|June 1, 2023
Additional boosting to the RV144 vaccine regimen increased Fc-mediated effector function magnitude but not durabilityZhanna Shubin, Sherry Stanfield-Oakley, Jiraporn Puangkaew, et al.
AIDS and Behavior|January 8, 2022
Attitudes About Analytic Treatment Interruption (ATI) in HIV Remission Trials with Different Antiretroviral Therapy (ART) Resumption CriteriaHolly L Peay, Stuart Rennie, R Jean Cadigan, et al.
Plos Pathogens|August 13, 2021
Abrupt and altered cell-type specific DNA methylation profiles in blood during acute HIV infection persists despite prompt initiation of ARTMichael J Corley, Carlo Sacdalan, Alina P S Pang, et al.
Pageof 13